The market value per capita for Penicillins and Streptomycins in Madagascar has seen a fluctuating yet upward trend from 2013 to 2023. In 2023, the market stood at $1.10 per capita. Over the past two years, there has been a slight shift in growth dynamics, with a 0.93% increase in 2022 but a rebound of 1.85% in 2023. The compound annual growth rate (CAGR) over the past five years is approximately 1.55%, indicating a steady but modest ascent in market engagement and consumption.

Future trends to watch include:

Potential impacts of healthcare policy changes on antibiotic accessibility.
Prospects and challenges of generic antibiotic introduction in the market.
The influence of global and regional public health campaigns on antibiotic demand.